1/10/2023 Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10. DOI: https://doi.org/10.1001/jamanetworkopen.2022.50394
12/29/2022 Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer Gong IY, Vijenthira A, Powis M, Calzavara A, Patrikar A, Sutradhar R, Hicks LK, Wilton D, Singh S, Krzyzanowska MK, Cheung MC. JAMA Oncol. 2022; Dec 29 [Epub ahead of print]. DOI: https://doi.org/10.1001/jamaoncol.2022.6815
11/4/2022 Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based study Ling Y, Cheung MC, Chan KKW, Lofters A, Fox C, Patrikar A, Liu N, Singh S. BMC Cancer. 2022; 22(1):1133. Epub 2022 Nov 4. DOI: https://doi.org/10.1186/s12885-022-10257-4
The Globe and Mail11/5/2018Article Additional screening for late-stage cancer patients has little benefit, study says